The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

Peterson, Kevin; Ruelle, Jean; Vekemans, Marc; Siegal, Frederick P; Deayton, Jane R; Colebunders, Robert

doi:10.3851/IMP2303

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

Peterson, Kevin

;

Ruelle, Jean

;

Vekemans, Marc

;

Siegal, Frederick P

;

Colebunders, Robert

;et.al.

(2012) Antiviral Therapy — Vol. 17, p. 1097-1100 (2012)

Files

Roleofraltegravir_2012.pdf

Restricted Access
Adobe PDF
143.03 KB

Request a copy

Details

Authors

Peterson, KevinInstitute of Tropical Medicine, Antwerp, Belgium
Author
Ruelle, JeanUCLouvain
Author
Vekemans, MarcInstitute of Tropical Medicine, Antwerp, Belgium
Author
Siegal, Frederick PMount Sinai Medical Center, New York, NY, USA
Author
Colebunders, RobertInstitute of Tropical Medicine and Unviversity of Antwerp, Antwerp, Belgium
Author

Abstract

We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4+ T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.

Affiliations

Citations

APA
Chicago
FWB

Peterson, K., Ruelle, J., Vekemans, M., Siegal, F. P., Deayton, J. R., & Colebunders, R. (2012). The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series. Antiviral Therapy, 17, 1097-1100. https://doi.org/10.3851/IMP2303 (Original work published 2012)